SCHEMBL2083008

SCHEMBL2083008

O=C1C=CC(C(=O)O)CC1

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.33
APEX1 P27695 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
NFKB1 P19838 2/20 0.33
NFKB2 Q00653 2/20 0.33
RELA Q04206 2/20 0.33
NLRP3 Q96P20 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2663988 0.77
SCHEMBL2598725 0.76 CYP1A2 (0.38) NFKB1NFKB2RELANLRP3
SCHEMBL13425089 0.71 NFKB1 (0.31) NFKB1NFKB2RELANLRP3
SCHEMBL638769 0.70 POLB (0.46) POLBAPEX1TDP1NFKB1
SCHEMBL3014862 0.70
SCHEMBL18709794 0.70
SCHEMBL19420224 0.70
SCHEMBL10673332 0.69 ITGB3 (0.34) POLBAPEX1TDP1NFKB1NFKB2
SCHEMBL13836558 0.69 NFKB1 (0.44) NFKB1NFKB2RELA
Hydroxyl Radical SCHEMBL7645832 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619376-A2 CYCLIC DESIGNER SCAFFOLDS FOR THE COVALENT TARGETING OF PROTEINS VIA MICHAEL ADDITION Protenic Fejleszto Es Szolgaltato Kft. (HU) 2025-09-24 EP disclosed
EP-4610288-A1 POLYMER PARTICLES WITH LIQUID ACTIVE MATERIALS IN CORE Lalgudi, Ramanathan S. (US) 2025-09-03 EP disclosed
EP-4448665-A1 BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS Lalgudi, Ramanathan S. (US) 2024-10-23 EP disclosed
US-20240254272-A1 BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS LALGUDI RAMANATHAN S (US) 2024-08-01 US disclosed
WO-2024105420-A2 CYCLIC DESIGNER SCAFFOLDS FOR THE COVALENT TARGETING OF PROTEINS VIA MICHAEL ADDITION Természettudományi Kutatóközpont (HU) 2024-05-23 WO disclosed
US-11932721-B2 Bio-based polyols, esters, and surfactants Lalgudi, Ramanathan S. (US) 2024-03-19 US disclosed
WO-2023114250-A1 BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS LALGUDI RAMANATHAN S (US) 2023-06-22 WO disclosed
US-20230183412-A1 BIO-BASED POLYOLS, ESTERS, AND SURFACTANTS LALGUDI RAMANATHAN S (US) 2023-06-15 US disclosed
US-8163944-B2 Allylic oxidations catalyzed by dirhodium catalysts under aqueous conditions UNIVERSITY OF MARYLAND COLLEGE PARK (US) 2012-04-24 US disclosed
US-20090093638-A1 Allylic Oxidations Catalyzed by Dirhodium Catalysts under Aqueous Conditions UNIVERSITY OF MARYLAND, COLLEGE PARK (US) 2009-04-09 US disclosed
US-6294676-B2 AS CHEMICAL INTERMEDIATE FOR PREPARING HERBICIDES AMERICAN CYANAMID COMPANY 2001-09-25 US disclosed
US-20010014745-A1 PROCESS FOR THE PREPARTION OF 6-(ARYLCARBONYL)-4-OXIMO-DIHYDROBENZOTHIOPYRAN HERBICIDES AND INTERMEDIATES USEFUL THEREIN DOEHNER JR ROBERT FRANCIS (US) 2001-08-16 US disclosed
EP-0915092-B1 Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein BASF AG (DE) 2001-06-13 EP disclosed
US-6008402-A REACTING CYCLOHEXADIENECARBOXYLATE-4-ONE COMPOUND WITH A BETA MERCAPTOPROPIONIC ACID TO GIVE THIOENOL, CYCLODEHYDRATING THE THIOENOL AMERICAN CYANAMID COMPANY (US) 1999-12-28 US disclosed
EP-0915092-A1 Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein American Cyanamid Company (US) 1999-05-12 EP disclosed
US-4996234-A Anticholesterol agents RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-02-26 US disclosed
US-4900754-A ANTICHOLESTEROL AGENTS RORER PHARMACEUTICAL CORP. (US) 1990-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093638-A1 Allylic Oxidations Catalyzed by Dirhodium Catalysts under Aqueous Conditions CYP11B2, DHCR7, ZDHHC7 POLB 1421/4885APEX1 222/4885TDP1 2878/4885
US-20010014745-A1 PROCESS FOR THE PREPARTION OF 6-(ARYLCARBONYL)-4-OXIMO-DIHYDROBENZOTHIOPYRAN HERBICIDES AND INTERMEDIATES USEFUL THEREIN DDT, CYP4X1, CYP2B6 POLB 1089/4885APEX1 1373/4885TDP1 1976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.